Sort
48,018 grants matching “immunotherapy”
Signal transduction and gene induction in lymphocytes
$540,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2021 · AI
Signal transduction and gene induction in lymphocytes
$540,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2020 · AI
C. albicans invasion and proliferation during oral infection
$539,989Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2021 · DE
T cell responses to CD1-restricted lipids in tuberculosis
$539,953David Branch Moody · Brigham And Women'S Hospital · R01 · FY2021 · AI
Delineating Functional Immunity via Image-Guided PET
$539,930Nerissa Therese Viola · Wayne State University · R37 · FY2021 · CA
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
$539,865Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Training Grant in Molecular Imaging Research
$539,842Ralph Weissleder · Massachusetts General Hospital · T32 · FY2017 · CA
Improving Patient Adherence to Cancer Treatment
$539,814University Of Southern California · R01 · FY2002 · CA
Allergen T cell epitopes and phenotypes during peanut immunotherapy
$539,802Erik Wambre · Benaroya Research Inst At Virginia Mason · U19 · FY2021 · AI
Overcoming Therapy Resistance in SCLC
$539,763Esra Akbay · Ut Southwestern Medical Center · R01 · FY2025 · CA
Naive T cell depletion to prevent graft-versus-host disease
$539,649Marie Bleakley · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL
Naive T cell depletion to prevent graft-versus-host disease
$539,649Marie Bleakley · Fred Hutchinson Cancer Research Center · R01 · FY2017 · HL
Naive T cell depletion to prevent graft-versus-host disease
$539,649Marie Bleakley · Fred Hutchinson Cancer Research Center · R01 · FY2018 · HL
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
$539,600Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2025 · CA
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
$539,533Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Acoustothermogenetics for Cell Engineering
$539,500Yingxiao Wang · University Of Southern California · R35 · FY2025 · GM
Novel strategies to improve mesothelioma therapy
$539,493Haining Yang · University Of Hawaii At Manoa · R01 · FY2024 · CA
Dissecting the pathways controlling tunable responses to TCR signaling
$539,481Leslie J. Berg · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
Magnetically directed single cell transcriptome analysis in HIV latency
$539,463David Martin Murdoch · Duke University · R01 · FY2017 · GM
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$539,448Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2025 · CA
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
$539,426Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$539,424Albert Folch · University Of Washington · R01 · FY2025 · CA
Acoustothermogenetics for Cell Engineering
$539,364Yingxiao Wang · University Of Southern California · R35 · FY2024 · GM
Differentiation of subsets of NKT cells
$539,188Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2016 · AI
Differentiation of subsets of NKT cells
$539,188Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2019 · AI